FindTrial
Sign In

A Study to evaluate the efficacy of Saindhavadi Rasakriya Anjana in the management of Blepharitis.

A RANDOMIZED OPEN LABEL COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF SAINDHAVADI RASAKRIYA ANJANA AND TRIPHALA RASAKRIYA ANJANA IN THE MANAGEMENT OF KRIMIGRANTHI WITH SPECIAL REFERENCE TO SEBORRHEIC BLEPHARITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033205
Enrollment
30
Registered
2021-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

Intervention1: Triphala Rasakriya Anjana: 1 drop twice a day - 15 days Control Intervention1: Saindahavdi Rasakriya Anjana: 1 drop twice a day - 15 days

Sponsors

Dr Sivasankari N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with the classical features of Krimigranthi. 2. Patients within the age of 21 to 60 years irrespective of gender, occupation, religion, socio- economic status and duration of illness.

Exclusion criteria

Exclusion criteria: 1. Associated with psoriasis and any other skin diseases. 2. Posterior Blepharitis. 3. Ulcerative Blepharitis 4. Parasitic Blepharitis. 5. Mixed Blepharitis. 6. Patients suffering with complications of blepharitis such as conjunctivitis and keratitis.

Design outcomes

Primary

MeasureTime frame
Reduction in blepharitis Subjective parameters - 1 Kandu 2 Oosha 3 Gharsha 4 Pakshma potavaan 5 Arthi 6 Ashru Timepoint: 0th day 16th day 22nd day 29th day—

Secondary

MeasureTime frame
Reduction in blepharitis Subjective parameters - 1 AshruTimepoint: 0th day 16th day 22nd day 29th day—

Countries

India

Contacts

Public ContactDr Sandhya Ganesh

Sri Sri College of Ayurvedic Science and Research Hospital

drsandyaganeshk@gmail.com9449349263

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026